Lupus

Slowing chronic kidney disease progression: results of prospective clinical trials in adults
Chronic kidney disease is generally thought to be a progressive disorder regardless of etiology.
5323 Harry Hines Blvd
Dallas, TX 75390-8856
USA
Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases
BACKGROUND: Systemic lupus erythematosus is an autoimmune disease with diverse clinical manifestations that cannot always be regulated by steroids and immunosuppressive therapy.

Tel Hashomer, Israel
Israel
Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic str
The management of systemic lupus erythematosus (SLE) has improved thanks to a better understanding of the immunopathogenesis of the disease and important advances in drug development.
Room 331, 3rd Floor, The Windeyer Building, 46 Cleveland Street
London, UK, Vigo, Spain
UK
Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concur
Studies of immunosuppressive therapy, particularly mycophenolate mofetil (MMF), in membranous lupus nephritis (MLN) are limited.

Baltimore, MD 21205
USA